Almirall (Barcelona, Spain) has launched its first call for innovation to start-ups focused on dermatology digital health. The Almirall initiative is part of an accelerator program (the Digital Garden) to strengthen the company’s commitment to digital innovation. The winning five start-ups will be announced on November 14 at the Frontiers Health 2019 event in Berlin, Germany. The winning project teams will begin a nine-month acceleration program in January 2020 at the Barcelona Health Hub headquarters, with the objective of securing venture capital funding. In addition, the start-ups will receive up to €50K in grants, mentoring from pharma industry experts, and the opportunity to leverage leading hospitals in Barcelona as "test beds" for digital pilots. Companies can apply at almiralldigitalgarden.com almirall.com
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.